Lleo A. SVR is the strongest predictor of occurrence and recurrence of hepatocellular carcinoma in HCV cirrhotic patients after treatment with DAAs: A prospective multi-centric Italian study. PS-154.
Peginterferon alfa-2a plus tenofovir bij hepatitis D?
jun 2019 | Hepatitis